Juhász-Nagy A - Search Results

1

Intracoronary endothelin-1 infusion combined with systemic isoproterenol treatment: antagonistic arrhythmogenic effects.

Kiss O, Zima E, Soós P, Kékesi V, Juhász-Nagy A, Merkely B. Kiss O, et al. Among authors: juhasz nagy a. Life Sci. 2004 Jun 18;75(5):537-48. doi: 10.1016/j.lfs.2003.11.033. Life Sci. 2004. PMID: 15158364

2

Endothelin-1-induced elevations in purine metabolite concentrations -- autoregulatory protection in the canine pericardium?

Zima E, Kékesi V, Nagy A, Losonczi L, Toma I, Soós P, Barát E, Huszár E, Merkely B, Horkay F, Juhász-Nagy A. Zima E, et al. Clin Sci (Lond). 2002 Aug;103 Suppl 48:202S-205S. doi: 10.1042/CS103S202S. Clin Sci (Lond). 2002. PMID: 12193086

3

Expressed monophasic action potential alternans before the onset of ventricular arrhythmias induced by intracoronary bolus administration of endothelin-1 in dogs.

Merkely B, Vágó H, Kiss O, Zima E, Szücs G, Gellér L, Juhász-Nagy A. Merkely B, et al. Clin Sci (Lond). 2002 Aug;103 Suppl 48:219S-222S. doi: 10.1042/CS103S219S. Clin Sci (Lond). 2002. PMID: 12193090

4

Locally different role of atrial natriuretic peptide (ANP) in the pericardial fluid.

Soós P, Juhász-Nagy A, Ruskoaho H, Hartyánszky I, Merkely B, Tóth M, Horkay F. Soós P, et al. Life Sci. 2002 Oct 11;71(21):2563-73. doi: 10.1016/s0024-3205(02)02088-x. Life Sci. 2002. PMID: 12270761

5

Changes of endothelin-1 and big endothelin-1 levels and action potential duration during myocardial ischemia-reperfusion in dogs with and without ventricular fibrillation.

Vágó H, Soós P, Zima E, Gellér L, Keltai K, Róka A, Kékesi V, Juhász-Nagy A, Merkely B. Vágó H, et al. Among authors: juhasz nagy a. J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S376-9. J Cardiovasc Pharmacol. 2004. PMID: 15838324

6

Ventricular tachycardias induced by intracoronary administration of endothelin-1 in dogs.

Tóth M, Solti F, Merkely B, Kékesi V, Horkay F, Szokodi I, Juhász-Nagy A. Tóth M, et al. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S153-5. J Cardiovasc Pharmacol. 1995. PMID: 8587349

7

Presence of immunoreactive endothelin-1 and atrial natriuretic peptide in human pericardial fluid.

Horkay F, Szokodi I, Selmeci L, Merkely B, Kékesi V, Vecsey T, Vuolteenaho O, Ruskoaho H, Juhász-Nagy A, Tóth M. Horkay F, et al. Life Sci. 1998;62(3):267-74. doi: 10.1016/s0024-3205(97)01105-3. Life Sci. 1998. PMID: 9488105

8

Verapamil reduces the arrhythmogenic effect of endothelin.

Solti F, Tóth M, Merkely B, Kékesi V, Gellér L, Szokodi I, Horkay F, Juhász-Nagy A. Solti F, et al. J Cardiovasc Pharmacol. 1998;31 Suppl 1:S386-7. doi: 10.1097/00005344-199800001-00110. J Cardiovasc Pharmacol. 1998. PMID: 9595491

9

Bradycardia increases the arrhythmogenic effect of endothelin.

Tóth M, Solti F, Merkely B, Kékesi V, Szokodi I, Horkay F, Juhász-Nagy A. Tóth M, et al. J Cardiovasc Pharmacol. 1998;31 Suppl 1:S431-3. doi: 10.1097/00005344-199800001-00123. J Cardiovasc Pharmacol. 1998. PMID: 9595504

10

Increased monophasic action potential dispersion in endothelin-1-induced ventricular arrhythmias.

Gellér L, Merkely B, Lang V, Szabó T, Fazekas L, Kékesi V, Kiss O, Horkay F, Schaldach M, Tóth M, Juhász-Nagy A. Gellér L, et al. J Cardiovasc Pharmacol. 1998;31 Suppl 1:S434-6. doi: 10.1097/00005344-199800001-00124. J Cardiovasc Pharmacol. 1998. PMID: 9595505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters